Purple Biotech Ltd, formerly Kitov Pharma Ltd, is an Israel-based clinical-stage company that develops drugs that overcome tumor-immune evasion and drug resistancetreat pain. Main products of the Company is NT-219 i CM-24. CM-24 is a monoclonal antibody blockin and NT-219 is a small molecule bi-specific inhibitor of two key cancer resistance pathways. The Company is also the owner of Consensi, a fixed-dose combination of celecoxib and amlodipine besylate, for the simultaneous treatment of osteoarthritis pain and hypertension.
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļPPBT
āļāļ·āđāļāļāļĢāļīāļĐāļąāļPurple Biotech Ltd
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļSep 03, 1978
āļāļĩāļāļĩāđāļEfron (Gil)
āļāļģāļāļ§āļāļāļāļąāļāļāļēāļ9
āļāļĢāļ°āđāļ āļāļāļēāļĢāļĢāļąāļāļĐāļēāļāļ§āļēāļĄāļāļĨāļāļāļ āļąāļĒDepository Receipt
āļŠāļīāđāļāļāļĩāļāļāļāļĢāļ°āļĄāļēāļSep 03
āļāļĩāđāļāļĒāļđāđ4 Oppenheimer St.
āđāļĄāļ·āļāļREHOVOT
āļāļĨāļēāļāļŦāļĨāļąāļāļāļĢāļąāļāļĒāđNASDAQ OMX - NASDAQ BASIC
āļāļĢāļ°āđāļāļĻIsrael
āļĢāļŦāļąāļŠāđāļāļĢāļĐāļāļĩāļĒāđ7670104
āđāļāļĢāļĻāļąāļāļāđ97239333121
āđāļ§āđāļāđāļāļāđhttps://purple-biotech.com/
āļŠāļąāļāļĨāļąāļāļĐāļāđāļĒāđāļāļāļāļāļŦāļļāđāļPPBT
āļ§āļąāļāļāļĩāđāđāļŠāļāļāļāļēāļĒāļāļĢāļąāđāļāđāļĢāļSep 03, 1978
āļāļĩāļāļĩāđāļEfron (Gil)
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Director
Mr. Avraham Ben-Tzvi
General Counsel, Secretary
General Counsel, Secretary
Mr. Shai Lankry, CPA
Chief Financial Officer
Ms. Suzana Nahum-Zilberberg, CPA
Ms. Suzana Nahum-Zilberberg, CPA
Director
Dr. Michael Schickler, Ph.D.
Dr. Michael Schickler, Ph.D.
Head of Clinical Operations
Head of Clinical Operations
Dr. Bertrand Liang
Chief Medical Officer
Dr. Eric K. Rowinsky, M.D.
Dr. Eric K. Rowinsky, M.D.
Chairman of the Board
Mr. Gil Efron, CPA
Director
Dr. Hadas Reuveni
Founder and Chief Technology Officer of TyrNovo (a subsidiary)
Founder and Chief Technology Officer of TyrNovo (a subsidiary)
Mr. Itzhak Israel
Director
āļāļđāđāļāļīāđāļĄāđāļāļīāļĄ
Mr. Robert E. (Rob) Gagnon
Mr. Robert E. (Rob) Gagnon
Director
Mr. Avraham Ben-Tzvi
General Counsel, Secretary
General Counsel, Secretary
Mr. Shai Lankry, CPA
Chief Financial Officer
Ms. Suzana Nahum-Zilberberg, CPA
Ms. Suzana Nahum-Zilberberg, CPA
Director
Dr. Michael Schickler, Ph.D.
Dr. Michael Schickler, Ph.D.
Head of Clinical Operations
Head of Clinical Operations
Dr. Bertrand Liang
Chief Medical Officer